ARCHIVES

In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 28 | July 11, 1975

Download PDF Visit The Full Archive

Related Articles

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

December 26, 2014

Breast Cancer: Pitt “Regrets” Any Harm, Expresses Pride In Fisher’s Work

September 5, 1997

DCT Board Okays Kaposi Study, Blocks Monitoring Plan

February 26, 1982

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

HHS Appoints 13 To Genetics Committee

January 17, 2003

ASCO Recommends End of Life Discussions

January 28, 2011